Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun 9;54(11):3746-55.
doi: 10.1021/jm101621u. Epub 2011 May 16.

Nobilamides A-H, long-acting transient receptor potential vanilloid-1 (TRPV1) antagonists from mollusk-associated bacteria

Affiliations

Nobilamides A-H, long-acting transient receptor potential vanilloid-1 (TRPV1) antagonists from mollusk-associated bacteria

Zhenjian Lin et al. J Med Chem. .

Abstract

New compounds nobilamides A-H and related known compounds A-3302-A and A-3302-B were isolated based upon their suppression of capsaicin-induced calcium uptake in a mouse dorsal root ganglion primary cell culture assay. Two of these compounds, nobilamide B and A-3302-A, were shown to be long-acting antagonists of mouse and human TRPV1 channels, abolishing activity for >1 h after removal of drug presumably via a covalent attachment. Other derivatives also inhibited the TRPV1 channel, albeit with low potency, affording a structure-activity profile to support the proposed mechanism of action. While the activities were modest, we propose a new mechanism of action and a new site of binding for these inhibitors that may spur development of related analogues for treatment of pain.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Time-dependent inhibition of TRPV1 by 5. HEK-293 cells were transfected with human wild type TRPV1 and pre-treated with compound 5 (375 μM), followed by application of capsaicin (25 μM). For comparison, cells were co-treated with both agents. The change in fluorescent response to Ca2+ (ΔF) was measured as a function of maximum fluorescence or of fluorescence rate (n=3).
Figure 2
Figure 2
Stability of TRPV1 inhibition. Compound 2 (375μM) was incubated with HEK-293 cells transfected with wild-type human TRPV1. Response to capsaicin was measured over a 1 h timecourse with washes at various intervals (x-axis). The change in fluorescent response to Ca2+ (ΔF) was measured as a function of maximum fluorescence or of fluorescence rate.
Figure 3
Figure 3
Mutational analysis of human TRPV1 inhibition. A. Compounds 2 (375μM) and 5 (375 μM) were pre-incubated with HEK-293 cells transfected with wild-type and mutant TRPV1 channels. Inhibition of the capsaicin response was compared. The change in fluorescent response to Ca2+ (ΔF) was measured as a function of maximum fluorescence or of fluorescence rate. B. Side view of a homology model of a single subunit of human TRPV1. Highlighted residues involved in capsaicin binding (green) and nobilamide binding (yellow: Cys; red: Phe), as well as residues whose mutation does not affect nobilamide binding. C. Side view of a homology model of the TRPV1 tetramer pore loop region showing residues and intra-molecular distance between residues involved in capsaicin or nobilamide binding (colors as in B). The ion pore runs through the middle of this diagram and is presumably blocked by nobilamide binding between F660 and/or C578 and C621, either within or between subunits of the functional tetramer.

References

    1. Wu LJ, Sweet TB, Clapham DE. International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family. Pharmacol Rev. 2010;62:381–404. - PMC - PubMed
    1. Gazzieri D, Trevisani M, Springer J, Harrison S, Cottrell GS, Andre E, Nicoletti P, Massi D, Zecchi S, Nosi D. Substance P released by TRPV1-expressing neurons produces reactive oxygen species that mediate ethanol-induced gastric injury. Free Radical Bio Med. 2007;43:1670. - PubMed
    2. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 1997;389:816–824. - PubMed
    1. Szallasi A, Appendino G. Vanilloid receptor TRPV1 antagonists as the next generation of painkillers. J Med Chem. 2004;47:2717–2723. - PubMed
    1. Malmberg AB, Bley KR, editors. Progress in Inflammation Research. Birkhäuser-Verlag; Boston: 2005. Turning up the Heat on Pain: TRPV1 Receptors in Pain and Inflammation.
    1. Gunthorpe MJ, Chizh BA. Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway. Drug Discov Today. 2009;14:56–67. - PubMed

Publication types

MeSH terms

LinkOut - more resources